Novartis Institues for BioMedical Reseach, Inc.
Regimes of FXR agonists
The invention provides novel regimens of farnesoid X receptor (FXR) agonist and methods for modulating the activity of farnesoid X receptors (FXRs) using novel regimes of specific FXR agonists, in particular for treating or preventing fibrotic or cirrhotic diseases or disorders, such as liver diseases.
Novartis AG
A A A A A A
A61K A61P A61K A61K A61K A61K
inventional inventional inventional inventional inventional additional
Rachel Bryan Andreas Patrick Michael Jin
Soon Laffitte Bauer Mueller Badman Chen